Analysts on Wall Street project that SoFi Technologies, Inc. (SOFI - Free Report) will announce quarterly earnings of $0.11 per share in its forthcoming report, representing an increase of 37.5% year over year. Revenues are projected to reach $1.11 billion, increasing 29.7% from the same quarter last year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Bearing this in mind, let's now explore the average estimates of specific SoFi Technologies metrics that are commonly monitored and projected by Wall Street analysts.
Analysts forecast 'Net Interest Income' to reach $714.41 million. The estimate indicates a change of +38% from the prior-year quarter.
The consensus among analysts is that 'Total Noninterest Income' will reach $404.45 million. The estimate points to a change of +20% from the year-ago quarter.
The combined assessment of analysts suggests that 'Total Interest Income' will likely reach $1.06 billion. The estimate suggests a change of +33.2% year over year.
Analysts expect 'Other' to come in at $76.93 million. The estimate indicates a change of +60.1% from the prior-year quarter.
Analysts' assessment points toward 'Technology products and solutions' reaching $53.92 million. The estimate points to a change of -40.6% from the year-ago quarter.
Analysts predict that the 'Loan origination, sales, and securitizations' will reach $111.75 million. The estimate indicates a change of +57.7% from the prior-year quarter.
The average prediction of analysts places 'Total Accounts - Technology Platform segment' at 137.06 million. The estimate compares to the year-ago value of 160.05 million.
Based on the collective assessment of analysts, 'Total Products - Financial Services segment' should arrive at 20.80 million. The estimate compares to the year-ago value of 14.86 million.
View all Key Company Metrics for SoFi Technologies here>>>
Shares of SoFi Technologies have demonstrated returns of -3.8% over the past month compared to the Zacks S&P 500 composite's +0.6% change. With a Zacks Rank #3 (Hold), SOFI is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Portland General Electric (POR - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis electric utility is expected to post quarterly earnings of $0.64 per share in its upcoming report, which represents a year-over-year change of -3%.
Revenues are expected to be $846.61 million, up 4.9% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 9.58% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Portland General Electric?For Portland General Electric, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Portland General Electric will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Portland General Electric would post earnings of $0.83 per share when it actually produced earnings of $0.58, delivering a surprise of -30.12%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Portland General Electric doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsXcel Energy (XEL - Free Report) , another stock in the Zacks Utility - Electric Power industry, is expected to report earnings per share of $0.79 for the quarter ended June 2026. This estimate points to a year-over-year change of +5.3%. Revenues for the quarter are expected to be $3.58 billion, up 9% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Xcel has been revised 0.5% down to the current level. Nevertheless, the company now has an Earnings ESP of -0.42%, reflecting a lower Most Accurate Estimate.
When combined with a Zacks Rank of #3 (Hold), this Earnings ESP makes it difficult to conclusively predict that Xcel will beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
KENNEDY SPACE CENTER, Fla.--(BUSINESS WIRE)--Starfighters Space, Inc. (“Starfighters Space” or the “Company”) (NYSE American: FJET), the space company operating the world's only commercial fleet of flight-ready Mach 2+ F-104 supersonic aircraft, today announced that, following a thorough evaluation process, its Audit Committee, with the approval of the Board of Directors has engaged CBIZ CPAs P.C. (“CBIZ CPAs”) to serve as the Company's independent registered public accounting firm. “Starfighte.
Investors in AAON, Inc. (AAON - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 16, 2026 $55 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for AAON shares, but what is the fundamental picture for the company? Currently, AAON is a Zacks Rank #3 (Hold) in the Building Products - Air Conditioner and Heating industry that ranks in the Top 19% of our Zacks Industry Rank. Over the last 30 days, one analyst has increased the earnings estimate for the current quarter, while none have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from $5.50 per share to $5.53 in that period.
Given the way analysts feel about AAON right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
SummaryOn July 15, J&J, a Legend Biotech Corporation partner, announced continued strong demand for Carvykti.Sales of this CAR-T cell therapy were $657 million in the second quarter, up 10.1% quarter-on-quarter and 49.7% year-on-year.Legend hasn't yet announced when it will publish its second-quarter report, but given Carvykti's sales, I expect it to beat consensus estimates.Moreover, LB2501, a CD19/CD20 CAR T-cell therapy, has shown promising results in the Phase 1 trial in the treatment of relapsed or refractory B-cell non-Hodgkin lymphoma.In this article, I explain why I continue to cover Legend Biotech with a Strong Buy rating. Tom Merton/OJO Images via Getty Images
Following my article "Legend Biotech: Undervalued Leader In The CAR-T Race," Legend Biotech Corporation (LEGN) shares rose as much as 55.8% to $37.2.
But over the past 5 weeks, they've returned to the -1σ band
3.49K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Newell Brands (NWL - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis consumer products company is expected to post quarterly earnings of $0.19 per share in its upcoming report, which represents a year-over-year change of -20.8%.
Revenues are expected to be $1.97 billion, up 1.7% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.02% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Newell Brands?For Newell Brands, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +5.36%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination indicates that Newell Brands will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Newell Brands would post a loss of$0.09 per share when it actually produced a loss of -$0.05, delivering a surprise of +44.44%.
Over the last four quarters, the company has beaten consensus EPS estimates just once.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Newell Brands appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
California Public Employees Retirement System increased its position in Knight-Swift Transportation Holdings Inc. (NYSE:KNX – Free Report) by 3.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 291,883 shares of the transportation company’s stock after buying an additional 8,653 shares during the quarter. California Public Employees Retirement System owned about 0.18% of Knight-Swift Transportation worth $16,807,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Wellington Management Group LLP boosted its stake in shares of Knight-Swift Transportation by 23.6% during the 4th quarter. Wellington Management Group LLP now owns 12,918,523 shares of the transportation company’s stock valued at $675,380,000 after buying an additional 2,468,293 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Knight-Swift Transportation by 1.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 8,397,338 shares of the transportation company’s stock valued at $439,016,000 after acquiring an additional 129,651 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Knight-Swift Transportation by 7.2% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 4,676,422 shares of the transportation company’s stock worth $244,250,000 after purchasing an additional 315,192 shares during the last quarter. Ensign Peak Advisors Inc lifted its stake in Knight-Swift Transportation by 50.4% in the fourth quarter. Ensign Peak Advisors Inc now owns 2,939,212 shares of the transportation company’s stock valued at $153,662,000 after buying an additional 984,422 shares during the last quarter. Finally, UBS Group AG lifted its position in Knight-Swift Transportation by 44.3% in the 4th quarter. UBS Group AG now owns 2,430,896 shares of the transportation company’s stock valued at $127,087,000 after purchasing an additional 745,787 shares during the last quarter. 88.77% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In A number of analysts have recently weighed in on the stock. UBS Group upped their price target on shares of Knight-Swift Transportation from $79.00 to $94.00 and gave the stock a “buy” rating in a research note on Monday, June 1st. Robert W. Baird increased their price target on Knight-Swift Transportation from $62.00 to $70.00 and gave the company an “outperform” rating in a research report on Thursday, April 23rd. Stephens raised shares of Knight-Swift Transportation to a “strong-buy” rating in a research note on Wednesday, July 8th. Susquehanna raised their price objective on Knight-Swift Transportation from $90.00 to $96.00 and gave the stock a “positive” rating in a research report on Thursday. Finally, Wells Fargo & Company boosted their price target on shares of Knight-Swift Transportation from $65.00 to $86.00 and gave the company an “overweight” rating in a report on Friday, June 5th. Three investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $84.44.
Get Our Latest Stock Report on Knight-Swift Transportation
Key Knight-Swift Transportation News Here are the key news stories impacting Knight-Swift Transportation this week:
Positive Sentiment: Knight-Swift beat second-quarter expectations, reporting EPS of $0.63 versus consensus around $0.49-$0.51 and revenue of $2.10 billion versus estimates near $2.05 billion, with revenue up 12.6% year over year. Earnings report and transcript Positive Sentiment: The company also issued third-quarter EPS guidance of $0.71 to $0.77, above the Street’s estimate of about $0.67, which suggests management sees continued momentum. Quarterly results announcement Positive Sentiment: Several Wall Street firms lifted price targets after the results, including Bank of America to $98, Stifel to $88, Susquehanna to $96, TD Cowen to $86, and JPMorgan to $84, reflecting improved sentiment around the stock. Analyst target updates Neutral Sentiment: JPMorgan kept a neutral rating despite raising its target, while the other firms maintained more constructive views such as buy or positive. JPMorgan update Knight-Swift Transportation Stock Performance Shares of KNX opened at $72.05 on Friday. The company has a market capitalization of $11.71 billion, a PE ratio of 277.13, a price-to-earnings-growth ratio of 0.85 and a beta of 1.18. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.70 and a quick ratio of 0.70. Knight-Swift Transportation Holdings Inc. has a one year low of $38.63 and a one year high of $82.86. The company’s fifty day moving average price is $75.53 and its 200 day moving average price is $64.92.
Knight-Swift Transportation (NYSE:KNX – Get Free Report) last released its earnings results on Wednesday, July 22nd. The transportation company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.12. The firm had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.05 billion. Knight-Swift Transportation had a return on equity of 3.50% and a net margin of 0.56%.The company’s revenue was up 12.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.21 EPS. Knight-Swift Transportation has set its Q3 2026 guidance at 0.710-0.770 EPS. As a group, analysts expect that Knight-Swift Transportation Holdings Inc. will post 2.21 earnings per share for the current year.
Knight-Swift Transportation Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 22nd. Stockholders of record on Monday, June 8th were paid a $0.20 dividend. The ex-dividend date was Monday, June 8th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.1%. Knight-Swift Transportation’s dividend payout ratio is currently 380.95%.
About Knight-Swift Transportation (Free Report)
Knight-Swift Transportation Holdings Inc (NYSE: KNX) is one of North America’s largest asset-based truckload carriers, offering a wide range of transportation and logistics services. The company was formed in 2017 through the merger of Knight Transportation and Swift Transportation, each with decades of experience in long-haul dry van and refrigerated freight. Since the merger, Knight-Swift has pursued a growth strategy that includes fleet expansions, targeted acquisitions, and investments in technology to enhance service reliability and network efficiency.
The company’s core business activities include full truckload operations for dry van, temperature-controlled and flatbed shipments.
Recommended Stories Five stocks we like better than Knight-Swift Transportation Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Knight-Swift Transportation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight-Swift Transportation and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAlphabet (NASDAQ:GOOG) Price Target Raised to $475.00 at Pivotal Research
NEXT HEADLINE »Dimensional Fund Advisors LP Boosts Stake in JPMorgan Chase & Co. $JPM
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against GoDaddy Inc. (“GoDaddy” or the “Company”) (NYSE: GDDY). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a GoDaddy investor and have suffered losses, or if you have information that could assist in the GoDaddy investigation, you may CLICK HERE to contact us.
A strong stock as of late has been Quest Diagnostics (DGX - Free Report) . Shares have been marching higher, with the stock up 10.5% over the past month. The stock hit a new 52-week high of $237.78 in the previous session. Quest Diagnostics has gained 31.3% since the start of the year compared to the -0.1% gain for the Zacks Medical sector and the 20.4% return for the Zacks Medical - Outpatient and Home Healthcare industry.
What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on July 23, 2026, Quest Diagnostics reported EPS of $3.12 versus consensus estimate of $2.81 while it beat the consensus revenue estimate by 2.15%.
For the current fiscal year, Quest Diagnostics is expected to post earnings of $10.72 per share on $11.83 in revenues. This represents a 8.83% change in EPS on a 7.25% change in revenues. For the next fiscal year, the company is expected to earn $11.56 per share on $12.39 in revenues. This represents a year-over-year change of 7.84% and 4.69%, respectively.
Valuation MetricsThough Quest Diagnostics has recently hit a 52-week high, what is next for Quest Diagnostics? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.
Quest Diagnostics has a Value Score of B. The stock's Growth and Momentum Scores are B and B, respectively, giving the company a VGM Score of B.
In terms of its value breakdown, the stock currently trades at 21.3X current fiscal year EPS estimates, which is a premium to the peer industry average of 20.9X. On a trailing cash flow basis, the stock currently trades at 15X versus its peer group's average of 14.8X. Additionally, the stock has a PEG ratio of 2.72. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Zacks RankWe also need to consider the stock's Zacks Rank, as this is even more important than the company's VGM Score. Fortunately, Quest Diagnostics currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Quest Diagnostics fits the bill. Thus, it seems as though Quest Diagnostics shares could have a bit more room to run in the near term.
How Does DGX Stack Up to the Competition?Shares of DGX have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is Aveanna Healthcare Holdings Inc. (AVAH - Free Report) . AVAH has a Zacks Rank of #2 (Buy) and a Value Score of A, a Growth Score of A, and a Momentum Score of B.
Earnings were strong last quarter. Aveanna Healthcare Holdings Inc. beat our consensus estimate by 38.46%, and for the current fiscal year, AVAH is expected to post earnings of $0.73 per share on revenue of $2.65 billion.
Shares of Aveanna Healthcare Holdings Inc. have gained 7.1% over the past month, and currently trade at a forward P/E of 12.44X and a P/CF of 13.17X.
The Medical - Outpatient and Home Healthcare industry is in the top 39% of all the industries we have in our universe, so it looks like there are some nice tailwinds for DGX and AVAH, even beyond their own solid fundamental situation.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Quest Diagnostics (DGX - Free Report) Headquartered in Secaucus, New Jersey, Quest Diagnostics Inc. provides diagnostic information services to a broad range of customers within its primary customer channels of physicians, hospitals, patients, and consumers. The company provides services to Independent Delivery Networks (IDN) throughout the United States, through its Professional Lab Services (PLS) offerings, which allow them to build and execute their laboratory strategy, improve quality, reduce healthcare costs, and focus on core competencies. The company is a key provider of reference testing for approximately half of the hospitals in the United States.
DGX is a #2 (Buy) on the Zacks Rank, with a VGM Score of B.
Momentum investors should take note of this Medical stock. DGX has a Momentum Style Score of B, and shares are up 10.5% over the past four weeks.
One analyst revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.02 to $10.72 per share. DGX also boasts an average earnings surprise of +5.8%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, DGX should be on investors' short list.
Represents significant milestone in the Company’s ongoing portfolio optimization efforts July 24, 2026 09:00 ET | Source: Surgery Partners, Inc.
BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it, along with its existing partner Intermountain Health, has placed into escrow signature pages to definitive agreements, pursuant to which Surgery Partners would sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health. Physician ownership of Mountain View Hospital will remain unchanged.
The transaction values the combined Idaho Falls facilities at approximately $1.15 billion. Total consideration to Surgery Partners is approximately $795 million. The Company expects to receive substantial cash proceeds upon closing, with the final amount subject to customary purchase price adjustments, including adjustments for indebtedness, working capital, transaction expenses and other closing items. Accordingly, the Company is unable to provide a reasonable estimate of final net cash proceeds at this time.
Completion of the transaction is subject to customary closing conditions, including the execution of binding Securities Purchase Agreements between the Company and Intermountain Health following requisite Mountain View Hospital physician member and physician governing board approvals. Unless and until these approvals are obtained, there is no assurance regarding the completion of the transaction.
In addition, the closing of the transaction is subject to customary closing conditions, including expiration of applicable waiting periods under the Hart-Scott-Rodino Act, obtaining any other applicable material regulatory approvals, and obtaining certain material third-party consents.
The transaction is expected to close in the coming months, subject to the forgoing approvals.
“For Surgery Partners, assuming physician partner approval, this transaction represents the largest step forward in our portfolio optimization strategy to date, simplifying our go forward operations, and positioning us to accelerate momentum in the rapidly growing, high-value ambulatory surgery center space,” said Eric Evans, Chief Executive Officer of Surgery Partners. “While our Idaho Falls partnerships have been a large and successful part of our Company’s growth story, these unique facilities are best positioned for their next chapter of growth with an outstanding regional health system like Intermountain. Once complete, this will further sharpen our strategic focus and help support long-term shareholder value. We are confident that Intermountain Health is the best natural owner to continue to advance the mission that Mountain View physician partners started well over two decades ago and to build on their strong legacy of exceptional patient care.”
2026 Outlook
The Company’s previously issued guidance does not reflect the anticipated impact of this transaction. Excluding the impact of this transaction, the Company reaffirms its outlook for 2026 revenues to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million.
The Company intends to provide further details regarding the expected financial impact of the transaction on its 2026 financial outlook at the appropriate time, subject to the completion of the transaction.
Second Quarter 2026 Earnings Release Date and Conference Call Details
Surgery Partners will release its second quarter 2026 results before the market opens on Monday, August 10, 2026, to be followed by a conference call at 8:30 a.m. (Eastern Time).
You can join the call as follows:
Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until August 24, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13761354
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call.
To learn more about Surgery Partners please visit the company’s website at www.surgerypartners.com. Surgery Partners uses its website as a channel of distribution of material company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company’s website and is readily accessible.
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com.
About the Idaho Falls Facilities
The Idaho Falls facilities have built a long-standing reputation as preferred providers and leaders in delivering high-quality, affordable care for the Idaho Falls region. Mountain View Hospital was founded in 2002 and has grown into a leading surgical hub and Level III NICU, with the opening of the Idaho Falls Community Hospital in 2019 adding scalable acute care capabilities. Combined, the locations employ over 150 physicians and include 126 beds with a breadth of services across nine surgical specialties and a diverse range of additional service lines, including oncology, emergency department and ICU services, and neonatology.
About Intermountain Health
Headquartered in Utah with locations in six states and additional operations across the western U.S., Intermountain Health is a nonprofit system of 34 hospitals, approximately 400 clinics, medical groups with some 4,600 employed physicians and advanced care providers, a nonprofit health plan called Select Health with more than one million members, and other health services. Helping people live the healthiest lives possible, Intermountain is committed to improving community health and is widely recognized as a leader in transforming healthcare by using evidence-based best practices to consistently deliver high-quality outcomes at sustainable costs.
This press release contains forward-looking statements, including those regarding growth, our anticipated operating results for future periods and other similar statements. These statements can be identified by the use of words such as "believes," "anticipates," "expects," "intends," "plans," "continues," "estimates," "predicts," "projects," "forecasts," "may," "could," and similar expressions. All forward-looking statements are based on current expectations and beliefs as of the date of this release and are subject to risks, uncertainties and other factors that may cause actual results to differ materially from the expectations discussed in, or implied by, the forward-looking statements. Many of these factors are beyond our ability to control or predict including, without limitation, the risk that the potential sale transaction may not be completed in a timely manner or at all, including the risk that required physician, regulatory and other approvals and consents are not obtained, are delayed, or are obtained subject to conditions that are not anticipated; the failure to satisfy other closing conditions to the transaction; the possibility that the anticipated benefits of the sale to the Company are not realized as expected, the potential adverse effect of the announcement or pendency of the transaction on the market price of, or trading in, the Company’s securities and on the Company's business relationships, operating results, and business generally, including the ability to retain key personnel; risks related to diverting management's attention from the Company's ongoing business operations; the amount of costs, fees, expenses, and charges related to the sale transaction; potential litigation relating to the transaction that could be instituted against the Company or its affiliates, officers, or directors, and the effects of any outcomes related thereto; reductions in payments from government health care programs and private insurance payors, such as health maintenance organizations, preferred provider organizations, and other managed care organizations and employers; our ability to contract with private insurance payors; changes in our payor mix or surgical case mix; failure to maintain or develop relationships with physicians on beneficial or favorable terms, or at all; the impact of payor controls designed to reduce the number of surgical procedures; our efforts to integrate operations of acquired or developed businesses and surgical facilities, attract new physician partners, or acquire additional surgical facilities; supply chain issues, including shortages or quality control issues with surgery-related products, equipment and medical supplies; competition for physicians, nurses, strategic relationships, acquisitions and managed care contracts; our ability to attract and retain qualified health care professionals; our ability to enforce non-compete restrictions against our physicians; our ability to manage material liabilities whether known or unknown incurred as a result of acquiring or operating surgical facilities; the impact of future legislation and other health care regulatory reform actions, and the effect of that legislation and other regulatory actions on our business; our ability to comply with current health care laws and regulations; the outcome of legal and regulatory proceedings that have been or may be brought against us; the impact of cybersecurity attacks or intrusions, changes in the regulatory, economic and other conditions of the states where our surgical facilities are located; our indebtedness; the social and economic impact of a pandemic, epidemic or outbreak of a contagious disease on our business; and the risks and uncertainties identified and discussed from time to time in the Company’s reports filed with the Securities and Exchange Commission (the "SEC"), including in Item 1A under the heading "Risk Factors" in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and other reports filed with the SEC. Except as required by law, the Company undertakes no obligation to revise or update publicly any forward-looking statements to reflect events or circumstances after the date of this report, or to reflect the occurrence of unanticipated events or circumstances.
Contacts
Media/Investor Contact
Surgery Partners Investor Relations
(615) 234-8940 [email protected]
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
#1 (Strong Buy) stocks have produced an unmatched +23.94% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Burlington Stores (BURL - Free Report) Founded in 1972 and headquartered in New Jersey, Burlington Stores, Inc. is a Fortune 500 company and an off-price retailer operating in the United States and Puerto Rico. Through its subsidiary, Burlington Coat Factory Warehouse Corporation, the company provides a line of value-priced products, including women’s ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats.
BURL is a #2 (Buy) on the Zacks Rank, with a VGM Score of B.
Additionally, the company could be a top pick for growth investors. BURL has a Growth Style Score of A, forecasting year-over-year earnings growth of 20% for the current fiscal year.
For fiscal 2027, five analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.36 to $11.71 per share. BURL boasts an average earnings surprise of +14%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, BURL should be on investors' short list.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?
Let's take a look at what these Wall Street heavyweights have to say about SkyWest (SKYW - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.
SkyWest currently has an average brokerage recommendation (ABR) of 1.86, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by seven brokerage firms. An ABR of 1.86 approximates between Strong Buy and Buy.
Of the seven recommendations that derive the current ABR, four are Strong Buy, representing 57.1% of all recommendations.
Brokerage Recommendation Trends for SKYW
Check price target & stock forecast for SkyWest here>>>
The ABR suggests buying SkyWest, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.
Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.
This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.
Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.
Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.
Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.
In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.
Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.
Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.
Should You Invest in SKYW?Looking at the earnings estimate revisions for SkyWest, the Zacks Consensus Estimate for the current year has declined 1% over the past month to $10.88.
Analysts' growing pessimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates lower, could be a legitimate reason for the stock to plunge in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for SkyWest. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Therefore, it could be wise to take the Buy-equivalent ABR for SkyWest with a grain of salt.
Wall Street analysts expect Sprouts Farmers (SFM - Free Report) to post quarterly earnings of $1.35 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $2.33 billion, up 4.9% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 1.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Sprouts Farmers metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, 'Comparable store sales growth' should come in at -0.8%. Compared to the current estimate, the company reported 10.2% in the same quarter of the previous year.
Analysts expect 'Stores at end of period' to come in at 492 . The estimate is in contrast to the year-ago figure of 455 .
The average prediction of analysts places 'New Stores Opened' at 8 . The estimate is in contrast to the year-ago figure of 12 .
The combined assessment of analysts suggests that 'Stores at beginning of period' will likely reach 483 . The estimate is in contrast to the year-ago figure of 443 .
View all Key Company Metrics for Sprouts Farmers here>>>
Shares of Sprouts Farmers have experienced a change of -10.4% in the past month compared to the +0.6% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), SFM is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Helen of Troy Limited (NASDAQ: HELE) common stock between April 24, 2024 and October 8, 2025. Helen of Troy markets a variety of consumer goods across several segments.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
What is the class period? April 24, 2024 - October 8, 2025
What are the allegations?
Shareholders allege that Helen of Troy Limited misled investors regarding the ability of Project Pegasus to improve efficiency and effectiveness. According to the complaint, in fiscal year 2023, Helen of Troy initiated Project Pegasus, a “global restructuring program that focused on both efficiency and effectiveness.” As a part of this initiative, the Company invested in a new distribution center in Tennessee to support its targeted growth.
Plaintiff alleges that during the class period, the Company boasted about the “fuel” it was generating from Project Pegasus. Although Helen of Troy admitted to some speed bumps in Project Pegasus, specifically citing “implementation hiccups” with its new Tennessee distribution center, defendants assured investors that “despite the delayed savings related to our Tennessee distribution center, Project Pegasus continues to move forward. We have made good progress on the cost of goods sold work streams, implementing multiple projects that reduce costs and simplify our supplier base.” However, Project Pegasus was not delivering the efficiencies that defendants touted. Rather, unknown to investors, Helen of Troy did not have enough resources or the budget to achieve its stated restructuring or savings goals.
Plaintiff alleges that on October 9, 2025, CEO G. Scott Uzzell reported Helen of Troy’s second quarter results for fiscal year 2026, announcing that quarterly sales were down 8.9% year-over-year, adjusted earnings per share plummeted by 51%, and that these results were caused by significant business disruptions and cost headwinds which the Company expects to persist for the remainder of the year. These disclosures caused Helen of Troy’s stock price to decline by $6.90 per share, or 25%.
What can shareholders do now? You may be eligible to participate in the class action against Helen of Troy Limited. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by August 3, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.
To be notified if a class action against Helen of Troy Limited settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
Miniatures of solar panel and electric pole are seen in front of Canadian Solar logo in this illustration taken January 17, 2023. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab
CompaniesJuly 24 (Reuters) - Canadian Solar (CSIQ.O), opens new tab opened a solar cell factory in Indiana on Friday that the company says will help fill a major gap in U.S. solar manufacturing by producing a key component that is largely produced in Asia.
The U.S. is seeking to build a domestic solar supply chain through tax incentives and trade measures aimed at reducing dependence on imports. China controls about 80% of the global solar supply chain.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
The nearly $1 billion investment by Canadian Solar's U.S. manufacturing arm, CS PowerTech, is expected to produce 6 gigawatts of cells annually and employ more than 1,200 people once it reaches full production by early next year.
"For us this is a tremendous milestone," Canadian Solar CEO Colin Parkin said in an interview.
Canadian Solar, which is based in Ontario, Canada, is one of the biggest solar equipment manufacturers in the world, with factories in China, Southeast Asia and the United States.
The Jeffersonville, Indiana, facility is the first U.S. plant designed to make heterojunction, or HJT, solar cells, a high-efficiency technology that Parkin said offers better performance than conventional technologies and has more room for future improvements.
The United States has added significant solar module assembly capacity since the 2022 Inflation Reduction Act created a tax credit for advanced clean energy manufacturing. But production of cells that are assembled into panels has lagged, leaving manufacturers dependent on imports.
Output from the Jeffersonville plant will be used by Canadian Solar's module factory in Mesquite, Texas, which is being expanded to 10 GW of annual capacity.
"It will directly reduce our reliance on imported cells," Parkin said, though the company will still depend on some imports.
U.S. tariffs on solar imports and manufacturing incentives helped justify the investment, Parkin said, adding that producing both cells and modules domestically allows the company to capture the full value of available tax incentives.
Canadian Solar is also actively evaluating investments further upstream in the solar supply chain, he said.
Reporting by Nichola Groom; Editing by Nia Williams
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks and waiting long for them to recover. They believe instead that one could make far more money in lesser time by "buying high and selling higher."
Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, investors find themselves loaded up on expensive shares with limited to no upside or even a downside. So, going all-in on momentum could be risky at times.
It could be safer to invest in bargain stocks that have been witnessing price momentum recently. While the Zacks Momentum Style Score (part of the Zacks Style Scores system), which pays close attention to trends in a stock's price or earnings, is pretty useful in identifying great momentum stocks, our 'Fast-Paced Momentum at a Bargain' screen comes handy in spotting fast-moving stocks that are still attractively priced.
There are several stocks that currently pass through the screen and Cleveland-Cliffs (CLF - Free Report) is one of them. Here are the key reasons why this stock is a great candidate.
Investors' growing interest in a stock is reflected in its recent price increase. A price change of 1.9% over the past four weeks positions the stock of this mining company well in this regard.
While any stock can see a spike in price for a short period, it takes a real momentum player to deliver positive returns for a longer time frame. CLF meets this criterion too, as the stock gained 7.5% over the past 12 weeks.
Moreover, the momentum for CLF is fast paced, as the stock currently has a beta of 2.13. This indicates that the stock moves 113% higher than the market in either direction.
Given this price performance, it is no surprise that CLF has a Momentum Score of A, which indicates that this is the right time to enter the stock to take advantage of the momentum with the highest probability of success.
In addition to a favorable Momentum Score, an upward trend in earnings estimate revisions has helped CLF earn a Zacks Rank #2 (Buy). Our research shows that the momentum-effect is quite strong among Zacks Rank #1 and #2 stocks. That's because as covering analysts raise their earnings estimates for a stock, more and more investors take an interest in it, helping its price race to keep up. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Most importantly, despite possessing fast-paced momentum features, CLF is trading at a reasonable valuation. In terms of Price-to-Sales ratio, which is considered as one of the best valuation metrics, the stock looks quite cheap now. CLF is currently trading at 0.33 times its sales. In other words, investors need to pay only 33 cents for each dollar of sales.
So, CLF appears to have plenty of room to run, and that too at a fast pace.
In addition to CLF, there are several other stocks that currently pass through our 'Fast-Paced Momentum at a Bargain' screen. You may consider investing in them and start looking for the newest stocks that fit these criteria.
This is not the only screen that could help you find your next winning stock pick. Based on your personal investing style, you may choose from over 45 Zacks Premium Screens that are strategically created to beat the market.
However, keep in mind that the key to a successful stock-picking strategy is to ensure that it produced profitable results in the past. You could easily do that with the help of the Zacks Research Wizard. In addition to allowing you to backtest the effectiveness of your strategy, the program comes loaded with some of our most successful stock-picking strategies.
Click here to sign up for a free trial to the Research Wizard today.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Hims & Hers Health, Inc. (HIMS - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Shares of this company have returned +0.1% over the past month versus the Zacks S&P 500 composite's +0.6% change. The Zacks Medical Info Systems industry, to which Hims & Hers Health belongs, has gained 5.3% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, Hims & Hers Health is expected to post a loss of $0.07 per share, indicating a change of -141.2% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.3% over the last 30 days.
For the current fiscal year, the consensus earnings estimate of -$0.27 points to a change of -150.9% from the prior year. Over the last 30 days, this estimate has changed -49.2%.
For the next fiscal year, the consensus earnings estimate of $0.52 indicates a change of +291.4% from what Hims & Hers Health is expected to report a year ago. Over the past month, the estimate has changed +2.5%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Hims & Hers Health is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Hims & Hers Health, the consensus sales estimate for the current quarter of $690.21 million indicates a year-over-year change of +26.7%. For the current and next fiscal years, $2.91 billion and $3.38 billion estimates indicate +23.8% and +16.4% changes, respectively.
Last Reported Results and Surprise HistoryHims & Hers Health reported revenues of $608.1 million in the last reported quarter, representing a year-over-year change of +3.8%. EPS of -$0.18 for the same period compares with $0.2 a year ago.
Compared to the Zacks Consensus Estimate of $619.62 million, the reported revenues represent a surprise of -1.86%. The EPS surprise was -550%.
Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates just once over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Hims & Hers Health is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Hims & Hers Health. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. ("Fulcrum Therapeutics" or the "Company") (NASDAQ: FULC).
CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION
If you are a Fulcrum Therapeutics investor and have suffered losses, or if you have information that could assist in the Fulcrum Therapeutics investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (212) 329-8571.
Fulcrum Therapeutics is a "clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with rare hematological disorders[.]"
On June 1, 2026, after market close, Fulcrum Therapeutics announced in a press release "the discontinuation of its pociredir program for the treatment of SCD [(sickle cell disease).]" The Company stated that the "meeting minutes from recent end-of-phase interactions with the [U.S. Food and Drug Administration ("FDA")]" "reflected heightened FDA concerns regarding pociredir's benefit-risk profile in SCD, stemming from an unexpectedly high rate of secondary hematologic malignancies observed with Tazverik® (tazemetostat), another PRC2 inhibitor, which was withdrawn from the global market in March 2026." After submitting further information, the FDA "concluded that any pharmacological intervention targeting the PRC2 complex carries equivalent malignancy risk regardless of the specific subunit engaged." As a result, the Company has "no viable regulatory path forward for further clinical development of pociredir."
Following this news, the price of Fulcrum Therapeutics stock declined from a closing price on June 1, 2026 of $6.42 per share to close at $3.14 per share on June 2, 2026, a decline of $3.28 per share, or by 51.09%.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
If you have any questions about this investigation, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
Reddit remains a Buy into Q2, with supportive valuations and a statistical edge for pre-earnings positioning despite recent volatility. RDDT's Q2 guidance implies 43-45% YoY revenue growth and a 40% EBITDA margin, but consensus expects a beat, even against tough comps. The Google licensing overhang introduces significant uncertainty, yet I see limited direct revenue risk and asymmetric upside if renegotiation occurs.
High-frequency trading firms are paying up to $100,000 a month for a direct API feed to President Trump’s Truth Social posts, according to Wall Street Journal reporting discussed on CNBC Friday morning. Gunjan Banerji, the Journal’s lead markets writer, walked through the mechanics of the arrangement and explained why algorithmic traders view the fee as a cost of doing business rather than a discretionary spend.
The service routes posts from Trump Media & Technology Group (NASDAQ:DJT) to subscribing firms through a low-latency data pipe. Trump Media says every post remains available to the public at the same moment it is delivered to paying clients, so the debate centers on how quickly each recipient can actually process the message and route trades to exchanges.
Why Nanoseconds Translate Into Dollars Banerji framed the stakes in the smallest possible time unit. “For the high frequency traders, the types of firms that are subscribing to this data, nanoseconds matter. We’re talking billionths of a second can make a difference in terms of their profits or losses,” she said. Algorithmic desks that trade equities, Treasury futures, currency pairs, and index derivatives can capture or lose meaningful spreads on a single Trump statement about tariffs, sanctions, or personnel.
The market has repeatedly demonstrated that sensitivity. In April 2025, Trump posted “THIS IS A GREAT TIME TO BUY!!!” on Truth Social hours before announcing a 90-day tariff pause, and stocks surged on the follow-up news. Traders who read the initial post ahead of the tape captured the move. Firms that saw it later paid a worse price.
The Wall Street vs. Main Street Question Banerji’s second point tied the pricing structure to a broader market-fairness issue. “This could shift the balance of power further towards Wall Street and away from many Main Street investors who might want to trade on this data,” she said. Retail investors watching Truth Social through the free consumer app receive the same words, only after the algorithms have already positioned around them.
The CNBC host highlighted the unprecedented layer. “Historically, when presidents or other federal officials have put news out, they also haven’t owned the device with which people are going to pay to get the milliseconds of news ahead of time,” he noted. Trump Media is controlled by the sitting president, which distinguishes the arrangement from feeds sold by neutral venues such as the NYSE or NASDAQ.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Trump Media & Technology Group didn't make the cut. Grab the names FREE today.
“No Choice” for the Subscribers Traders told the Journal that opting out would leave them behind competitors already on the feed. “We haven’t had a president who’s profiting from these payments before. But then they went on to say, look, we have to do this. We have no choice but to subscribe to this feed if we want to keep up with our competitors,” Banerji said. The dynamic mirrors how HFT shops treat exchange colocation and proprietary market-data products, where sitting out is the same as paying to lose.
Lawmaker Pushback Several Democratic senators have raised concerns. “Senator Warner of Virginia said this amounts to self-dealing by the president. He said this creates a two-tiered system for market data. Elizabeth Warren has spoken out against it. So has Chuck Schumer,” the host said. Warner, Warren, and Schumer have publicly flagged potential emoluments clause and market-structure issues, though no court or regulator has ruled that any law has been violated.
Trump Media’s counter is that simultaneity of publication removes the legal problem: everyone technically receives the post at the same instant, and firms are paying for delivery infrastructure rather than exclusive content. Details of the offering, including subscriber counts and contract terms, have been disclosed in company communications and can be tracked through Trump Media’s filings with the SEC.
For investors, the open question is whether the venture can sustainably monetize presidential communications and whether Congress or regulators eventually restrict the model. The commercial logic is straightforward. The governance question remains unresolved.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Trump Media & Technology Group didn't make the cut. Grab the names FREE today.
Investors in Hudson Pacific Properties, Inc. (HPP - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 18, 2026 $2.50 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for Hudson Pacific Properties shares, but what is the fundamental picture for the company? Currently, Hudson Pacific Properties is a Zacks Rank #1 (Strong Buy) in the REIT and Equity Trust – Other industry that ranks in the Top 24% of our Zacks Industry Rank. Over the last 30 days, two analysts have increased their earnings estimates for the current quarter, while none have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from 24 cents per share to 28 cents in that period.
Given the way analysts feel about Hudson Pacific Properties right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
Silver has dropped to 58.590 on the weekly chart, breaking beneath the $60 base of its 2026 range after peaking near $128. Source: TradingView The silver market rallied during the trading week to break above the $60 level at one point in time, but as we head into the weekend, it looks like $60 is going to continue to be important. With that being the case, I think you have to look at this through the prism of a market that has a lot of decisions to make here, and a market that, quite frankly, will remain noisy and concerned about the idea of interest rates being higher than usual. As interest rates climb, typically that will put downward pressure on silver, and that is something worth keeping an eye on.
Key Market Levels If the market can break sustainably above $60, that would be a big victory. The 50-week EMA currently sits at $63.68, but pay close attention to the last couple of candlesticks right around $55. We’ve seen support there, so if that were to give way, that would obviously be a technically bearish signal. If that happens, we could see other assets moving as well, as it would be a decidedly “risk-off” signal.
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.
Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.
On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.
One company value investors might notice is Signet Jewelers (SIG - Free Report) . SIG is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A.
SIG is also sporting a PEG ratio of 1.04. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. SIG's industry has an average PEG of 1.06 right now. SIG's PEG has been as high as 3.86 and as low as 0.39, with a median of 0.94, all within the past year.
Another valuation metric that we should highlight is SIG's P/B ratio of 2.27. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 3.66. Over the past year, SIG's P/B has been as high as 2.52 and as low as 1.04, with a median of 1.87.
Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's sales. Some people prefer this metric because sales are harder to manipulate on an income statement. This means it could be a truer performance indicator. SIG has a P/S ratio of 0.52. This compares to its industry's average P/S of 0.84.
These are just a handful of the figures considered in Signet Jewelers's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that SIG is an impressive value stock right now.
C3.ai, Inc. (AI - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this company have returned -6.9% over the past month versus the Zacks S&P 500 composite's +0.6% change. The Zacks Computers - IT Services industry, to which C3.ai belongs, has lost 0.9% over this period. Now the key question is: Where could the stock be headed in the near term?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, C3.ai is expected to post a loss of $0.26 per share, indicating a change of +29.7% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
For the current fiscal year, the consensus earnings estimate of -$0.82 points to a change of +39.3% from the prior year. Over the last 30 days, this estimate has remained unchanged.
For the next fiscal year, the consensus earnings estimate of $0.5 indicates a change of +39.8% from what C3.ai is expected to report a year ago. Over the past month, the estimate has remained unchanged.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, C3.ai is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For C3.ai, the consensus sales estimate for the current quarter of $51.46 million indicates a year-over-year change of -26.8%. For the current and next fiscal years, $221.58 million and $240.78 million estimates indicate -11.5% and +8.7% changes, respectively.
Last Reported Results and Surprise HistoryC3.ai reported revenues of $51.6 million in the last reported quarter, representing a year-over-year change of -52.5%. EPS of -$0.33 for the same period compares with -$0.16 a year ago.
Compared to the Zacks Consensus Estimate of $49.75 million, the reported revenues represent a surprise of +3.72%. The EPS surprise was +13.16%.
Over the last four quarters, C3.ai surpassed consensus EPS estimates three times. The company topped consensus revenue estimates two times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
C3.ai is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about C3.ai. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Americké zbrojovky, které tento týden přijely na aerosalon ve Farnborough, aby využily růstu evropských výdajů na obranu, se setkaly s obavami ze závislosti na amerických dodavatelích. Evropské vlády požadují větší kontrolu nad obrannou technikou, vyšší podíl místní výroby a větší zapojení domácího průmyslu. Američtí výrobci zbraní proto v Evropě zakládají společné podniky a nabízejí výrobky více přizpůsobené požadavkům jednotlivých evropských zemí, uvedla dnes agentura Reuters.
"Slyšíme to zcela jasně: Evropané chtějí větší suverenitu a chtějí mít více výrobních a technologických kapacit přímo u sebe,“ uvedl viceprezident americké společnosti Lockheed Martin pro globální rozvoj a strategii Daniel Tenney.
V době, kdy evropské členské státy Severoatlantické aliance a Kanada výrazně zvyšují výdaje na obranu, americké firmy argumentují, že nákup osvědčených amerických zbraňových systémů je rychlejší a levnější než vývoj nových. Současně však slibují lokalizaci výroby i přenos technologií do Evropy.
Společnost Lockheed Martin ve Farnborough představila levnější střelu pro systém protivzdušné obrany Patriot, která má být vyvinuta ve spolupráci s evropskými i americkými partnery. Oznámení přišlo krátce po zveřejnění plánů vyrábět taktické rakety Army Tactical Missile System (ATACMS) společně s německou společností Rheinmetall.
Divize Raytheon americké společnosti RTX nedávno rovněž oznámila partnerství s evropskými firmami s cílem zvýšit výrobu protiletadlových střel Stinger, včetně jejich finální montáže v Nizozemsku.
Evropské země podle prezidenta divize pozemních a protivzdušných obranných systémů společnosti Raytheon Thomase Lalibertyho těží z využívání široce rozšířených systémů, jako je Patriot. Země, které tento systém provozují, společně financují například databáze hrozeb či další společné schopnosti.
"Z této spolupráce mají značný prospěch,“ uvedl Laliberty.
Na evropském trhu zbrojní techniky se snaží prosadit i nové technologické společnosti. Firma Anduril, která se letos ve Farnborough představila dosud největší expozicí, rozšířila počet zaměstnanců v Británii a dohodla se na zahájení místní výroby střel s plochou dráhou letu Barracuda-500M v Polsku.
"Každá vláda má jiné požadavky na lokalizaci výroby," uvedl ředitel britské pobočky společnosti Anduril Richard Drake.
Část evropských představitelů se však obává, že Spojené státy by v budoucnu mohly být méně ochotné nebo méně schopné dodávat zbraně, náhradní díly či další podporu. Důvodem může být například situace, kdy by americké zbrojovky musely upřednostnit potřeby amerických ozbrojených sil v jiných částech světa.
Podle představitelů obranného průmyslu a odborníků už Evropané nechtějí pouze nakupovat hotové výrobky. Požadují přístup k technologiím, které jim umožní techniku samostatně vyrábět, upravovat i udržovat.
Evropa podle vedoucího partnera poradenské společnosti Boston Consulting Group v Miláně Fabia Dal Pana požaduje významný přenos práv duševního vlastnictví.
Přestože Evropa zůstává na americkém obranném průmyslu stále výrazně závislá, pro americké společnosti představuje riziko možnost, že se trend směřující k větší evropské soběstačnosti stane dlouhodobým. To je podle Toma Waldwyna z londýnského Mezinárodního institutu pro strategická studia (IISS) velmi závažná obava.
Existují přitom systémy, které Evropa nedokáže v krátké době nahradit, například stíhací letouny F-35 nebo protiraketové systémy Patriot. V jiných oblastech však podle analytika společnosti Agency Partners Sashe Tusy evropské alternativy "mohou být dostatečně kvalitní" a současně nabízejí významnou výhodu z hlediska strategické suverenity. V některých případech mohou být i levnější. To se podle něj týká například systémů protivzdušné obrany středního dosahu.
Analytici zároveň upozorňují, že Evropa už v některých segmentech postupně snižuje závislost na americké technice, například v oblasti letounů včasné výstrahy.
NATO nedávno oznámilo plán zhruba za 4,5 miliardy dolarů (95 miliard Kč) na nákup až deseti průzkumných letounů Saab GlobalEye, které mají nahradit stárnoucí stroje AWACS. Aliance tak dala přednost švédskému systému před konkurenční nabídkou amerického výrobce Boeing.
Evropské země se zároveň snaží samostatně vyvíjet některé nové technologie. Britská společnost BAE Systems na veletrhu ve Farnborough představila nový bezpilotní bojový letoun, který britská vláda označila za demonstrátor budoucí operační koncepce. Stalo se tak navzdory tomu, že několik amerických společností už podobné stroje vyvíjí a některé z nich byly ve Farnborough rovněž vystaveny.
Britský program bude zahrnovat více dodavatelů, zároveň však zůstane suverénní, řekl minulý týden agentuře Reuters zástupce velitele britského Královského letectva pro rozvoj schopností a programy Jim Beck.
"My potřebujeme mít právo rozhodovat o tom, jak a kdy budeme s naší technikou nakládat,“ uvedl Beck.
Aerosalon ve Farnborough se koná jednou za dva roky a střídá se s pařížským aerosalonem v Le Bourget. V sudých letech je v Británii, v lichých ve Francii. Jde o dvě nejvýznamnější světové přehlídky letecké techniky zaměřené na obchodní část odvětví, tedy především na kontrakty výrobců letadel, motorů, zbrojních firem a dodavatelů technologií.
Index Dow Jones +0,27 % na 51848,77 b., S&P 500 +0,11 % na 7416,35 b., Nasdaq Composite -0,47 % na 25018,65 b.
Americké akcie se v úvodu páteční seance obchodují smíšeně, když investoři vyhodnocují další várku kvartálních výsledků. Zatímco indexy Dow Jones a S&P 500 mírně rostou, technologický Nasdaq ztrácí, přičemž pod tlakem zůstávají informační technologie. Naopak se daří realitnímu, energetickému a zdravotnickému sektoru.
Telekomunikační společnost Verizon reportovala za 2Q očištěný zisk na akcii ve výši 1,30 USD, čímž překonala očekávání analytiků na úrovni 1,27 USD. Volné peněžní toky meziročně vzrostly o 24,4 % na 6,4 mld. USD a počet nových zákazníků širokopásmového připojení dosáhl 348 tis. Společnost zvýšila celoroční výhled očištěného zisku na akcii na 4,99 až 5,04 USD (z 4,95 až 4,99 USD) a očekává růst volných peněžních toků o 9 až 10 %. Analytici pozitivně hodnotili nižší odchodovost zákazníků a příznivý vývoj hospodaření. Akcie Verizonu přidávají 2,94 %.
Kabelový operátor Charter Communications vykázal za 2Q tržby ve výši 13,53 mld. USD, které meziročně poklesly o 1,7 %, ale mírně překonaly očekávání trhu. Očištěný zisk EBITDA meziročně klesl o 4,3 % na 5,45 mld. USD a zaostal za konsensem ve výši 5,58 mld. USD, přičemž nižší než očekávané byly rovněž volné peněžní toky (0,97 mld. USD oproti očekávaným 1,14 mld. USD). Počet zákazníků internetových služeb se snížil o 166 tis., zatímco počet mobilních linek vzrostl o 406 tis. Společnost nadále očekává celoroční kapitálové výdaje přibližně 11,4 mld. USD. Akcie Charter Communications odepisují 4,45 %.
Také telekomunikační a mediální konglomerát Comcast reportoval své kvartální výsledky za 2Q roku 2026. Výnosy sice meziročně poklesly o 1,2 %, překonaly však očekávání analytiků. Nad odhady se umístil rovněž očištěný zisk na akcii a volné peněžní toky. Streamovací služba Peacock poprvé vykázala kladný očištěný zisk EBITDA, když těžila mimo jiné z vysílání play-off NBA a mistrovství světa ve fotbale. Akcie Comcast +1,67 %.
Americká finanční společnost American Express reportovala za 2Q zisk na akcii ve výši 4,53 USD, nad očekáváním analytiků na úrovni 4,41 USD. Tržby meziročně vzrostly o 10 % na 19,64 mld. USD, avšak mírně zaostaly za konsensem, obdobně jako příjmy z poplatků za karty (2,86 mld. USD oproti očekávaným 3,01 mld. USD). Pozitivně překvapily nižší opravné položky na úvěrové ztráty, které meziročně poklesly o 21 % na 1,1 mld. USD. Společnost zvýšila celoroční výhled růstu tržeb na 10 %. Akcie American Express -6,06 %.
Americká společnost SLB (dříve Schlumberger), která poskytuje služby v oblasti ropného průmyslu vykázala za 2Q očištěný zisk na akcii ve výši 0,55 USD, zatímco analytici očekávali 0,51 USD. Tržby meziročně vzrostly o 5 % na 8,97 mld. USD, přičemž růst ve většině zahraničních regionů a vyšší výnosy divize Production Systems (3,77 mld. USD, +24 % meziročně) kompenzovaly slabší vývoj na Blízkém východě. Volné peněžní toky dosáhly 716 mil. USD a výrazně překonaly konsensus ve výši 327 mil. USD. Analytici vyzdvihli zejména rychlý růst segmentu datových center a přínos akvizice ChampionX. Akcie SLB přidávají 9,66 %.
Akcie výrobce paměťových medií Sandisk odepisují 8,5 %, když investoři upravovali své pozice před zveřejněním kvartálních výsledků a vybírali zisky v sektoru paměťových čipů.
Index S&P 500 +0,11 % na 7416,35 b. Nejsilnější sektory S&P Změna Nejslabší sektory S&P Změna Reality +2,5 % Informační technologie -0,7 % Energie +1,2 % Zbytná spotřeba -0,1 % Zdravotní péče +0,9 % Finanční sektor +0,2 % Nejsilnější akcie S&P Změna Nejslabší akcie S&P Změna Digital Realty Trust (DLR) +14 % Sandisk Corp (SNDK) -8,5 % SLB (SLB) +9,5 % Coherent Corp (COHR) -8,0 % Equinix (EQIX) +6,7 % CH Robinson Worldwide (CHRW) -6,8 % Universal Health Services (UHS) +6,3 % Lumentum Holdings (LITE) -6,7 % ServiceNow (NOW) +5,1 % Robinhood Markets (HOOD) -6,6 %
Zdroj: Bloomberg
Index nákupních manažerů PMI ve výrobě (S&P Global) (červenec - předběžný):
aktuální hodnota: 53,8 b.
očekávání trhu: 54,4 b.
předchozí hodnota: 53,9 b.
Index nákupních manažerů PMI ve službách (S&P Global) (červenec - předběžný):
aktuální hodnota: 53,6 b.
očekávání trhu: 51,5 b.
předchozí hodnota: 51,2 b.
Index nákupních manažerů PMI - kompozitní (S&P Global) (červenec - předběžný):
aktuální hodnota: 53,6 b.
očekávání trhu: 52,2 b.
předchozí hodnota: 51,9 b.
Banxa Brings Fiat On-Ramp Access to Arbitrum's USDCArbitrum has announced that users can now purchase $USDC directly on the Arbitrum network through Banxa, the regulated fiat-to-crypto payment gateway. The integration covers bank transfers, debit and credit cards, and local payment methods, broadening the ways users can fund positions on one of Ethereum's most active Layer 2 networks.
The move lowers a practical barrier for new and existing users. Rather than acquiring USDC on a centralised exchange and bridging it across, buyers can now land the asset directly on Arbitrum in a single step. Circle launched USDC natively on Arbitrum One in June 2023, adding support for its Cross-Chain Transfer Protocol, which enabled direct minting and burning of USDC between Ethereum and Arbitrum One. As of March 2025, there was over $3.5 billion of USDC in circulation on Arbitrum.
Banxa's Global Payment ReachBanxa is available in more than 180 countries, with support for over 30 fiat currencies and local payment methods worldwide. The company operates as a fiat-to-crypto payment gateway primarily serving crypto exchanges, wallets, and other blockchain platforms that require compliant and secure fiat on-ramps, with a focus on regulatory compliance, fraud prevention, and user verification.
The Arbitrum integration adds to a growing list of blockchain networks where Banxa has established a presence, which already includes Ethereum, Base, Solana, Polygon, Avalanche, and others. Purchase eligibility for $USDC on Arbitrum is subject to applicable order conditions, and availability may vary by region.
For the Arbitrum ecosystem, the partnership represents a more direct path from fiat to on-chain activity, particularly for users in markets where access to centralised exchanges is limited or where local payment rails are preferred over card-based options.
Sources:
Arbitrum Docs: USDC on Arbitrum One
USDC.com: How to Get USDC on Arbitrum
Banxa: On-Ramp and Off-Ramp Solutions
Booz Allen Hamilton (BAH - Free Report) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.49 per share. This compares to earnings of $1.48 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +21.48%. A quarter ago, it was expected that this defense contractor would post earnings of $1.32 per share when it actually produced earnings of $1.78, delivering a surprise of +34.85%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Booz Allen, which belongs to the Zacks Consulting Services industry, posted revenues of $2.8 billion for the quarter ended June 2026, in line with the Zacks Consensus Estimate. This compares to year-ago revenues of $2.92 billion. The company has not been able to beat consensus revenue estimates over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Booz Allen shares have lost about 21.9% since the beginning of the year versus the S&P 500's gain of 8.2%.
What's Next for Booz Allen?While Booz Allen has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Booz Allen was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.58 on $2.87 billion in revenues for the coming quarter and $6.31 on $11.41 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Consulting Services is currently in the bottom 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Information Services Group (III - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.
This market advisory service company is expected to post quarterly earnings of $0.09 per share in its upcoming report, which represents a year-over-year change of +12.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Information Services Group's revenues are expected to be $62.75 million, up 1.9% from the year-ago quarter.
U.S. stocks were mixed, with the Dow Jones index gaining around 0.2% on Friday.
Shares of Booz Allen Hamilton Holding Corporation (NYSE:BAH) rose sharply following upbeat quarterly earnings.
Booz Allen Hamilton posted adjusted earnings of $1.81 per share, beating market estimates of $1.49 per share. The company’s sales came in at $2.800 billion versus estimates of $2.820 billion.
Booz Allen Hamilton shares surged 13.1% to $74.51 on Friday.
Here are some other big stocks recording gains in today’s session.
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
The Pentagon's AI Pivot Supercharges Defense StocksBooz Allen Hamilton NYSE: BAH reported first-quarter fiscal 2027 revenue of $2.8 billion, down 4.2% from a year earlier, as growth in its national security portfolio was offset by continued weakness in civil work. The government-services company said profitability and cash flow exceeded its expectations and reaffirmed its full-year guidance.
Adjusted EBITDA rose to $334 million, producing an adjusted EBITDA margin of 11.9%, up 130 basis points year over year. Adjusted diluted earnings per share increased 22% to $1.81. Chief Financial Officer Troy Lahr said earnings benefited from profit growth, a lower tax rate, fewer shares outstanding and a $19 million pretax unrealized gain on a venture investment.
Get Booz Allen Hamilton alerts:
Catching Falling Knives: Is It Time to Buy These Beaten-Down Stocks?Free cash flow was $261 million in the quarter, supported by strong collections and favorable timing, according to Lahr. Days sales outstanding increased by seven days year over year to 80 days, which the company attributed to revenue-recognition treatment related to its Defy business. Booz Allen expects DSO to remain above its historical level.
National Security Growth Offsets Civil Pressure National security revenue grew 1% year over year in the first quarter, while civil revenue declined 16%. Lahr said the company expects national security revenue to grow at a mid-single-digit rate for the full fiscal year, with stronger growth in the second half as new work ramps up.
Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockCivil revenue continued to face pressure from the roll-off of larger contracts, prior contract reductions, Treasury-related impacts and fewer new program starts after a slower award environment last year. The company also said some recompete awards are transitioning to follow-on contracts with smaller scopes and shorter performance periods.
Booz Allen expects another sequential double-digit decline in civil revenue in the second quarter as additional contracts end, though management expects those pressures to ease gradually in the second half. President and COO Kristine Martin Anderson said the company still expects civil revenue to decline by a high-single-digit percentage for the year, an improvement from the prior year.
“Demand is strengthening, and we are winning work,” Anderson said of the civil portfolio, pointing to an expanding pipeline and efforts to bring the company’s cyber and defense technology solutions into civil agencies.
Funding trends improved during the quarter. Chairman and CEO Horacio Rozanski said funding was up 17% year over year, while Anderson said funding rose about 18% in both civil and national security. Funded backlog increased 15% to $4.7 billion, while total backlog rose 3% to more than $39 billion. The company’s book-to-bill ratio was 1.5 times in the quarter and 1.1 times on a trailing 12-month basis.
National security funded backlog increased 23%, and management said it is accelerating hiring to support anticipated growth. Anderson noted that the company is facing some supply constraints in recruiting personnel with security clearances.
Government Contracting Changes and Funding Uncertainty Management said the market remains uneven despite improving funding. Rozanski cited the midterm election year, potential continuing resolutions, the National Defense Authorization Act, possible reconciliation legislation and potential supplemental funding as factors that could affect the government funding environment later in the year.
The company is also preparing for a government push toward fixed-price and outcomes-based contracts. Anderson said recent guidance directs agencies to use firm fixed-price contracting as the default for new contracts unless an exception is approved. Booz Allen welcomed the shift, saying it could improve alignment between costs, accountability and mission results while offering more flexibility in delivery.
“Early indications are positive,” Rozanski said, while adding that the transition will take time because existing contracts do not convert immediately. Lahr said the company’s first-quarter profitability benefited in part from early shifts toward outcomes-based fixed-price contracting.
Anderson also said Booz Allen’s pipeline of other transaction authority opportunities increased 18% year over year. The company has been placing technology offerings on government marketplaces including Tradewind, Aeris and Platform One, which management said can provide faster procurement channels.
Cyber, Defense Technology and Ultra Acquisition Rozanski highlighted cyber and defense technology as the company’s primary growth vectors. He said agentic artificial intelligence is changing the cyber threat environment by enabling more autonomous attacks and that Booz Allen is expanding Vellox, its suite of agentic cyber products. He cited the company’s zero-trust capabilities and its Ranger product, which is designed to help organizations identify and remediate vulnerabilities at AI speed.
In defense technology, the company is focusing on command-and-control software, edge computing, resilient communications and autonomy. Booz Allen expects to close its acquisition of Ultra I&C Mission Solutions during the second quarter. The business brings products spanning command-and-control software, ruggedized edge computing and encryption management.
Lahr said Ultra is expected to deliver strong double-digit revenue growth for the next several years and EBITDA margins above 20%, though he did not provide a revenue run rate. Booz Allen plans to update guidance after the transaction closes.
The company deployed $447 million during the quarter, including $324 million for the Defy acquisition and venture investments, along with $123 million for dividends and share repurchases. It ended the quarter with $540 million in cash, $2 billion in total liquidity and net leverage of 2.7 times trailing-12-month adjusted EBITDA.
Booz Allen said it will continue pursuing a balanced capital-allocation strategy, including shareholder returns, venture investments and acquisitions that can accelerate its cyber and defense technology businesses.
About Booz Allen Hamilton (NYSE:BAH)Booz Allen Hamilton Holding Corporation is a publicly traded management and technology consulting firm headquartered in McLean, Virginia. The company provides a wide range of professional services and solutions in strategy, analytics, digital transformation, engineering and cyber security. Its expertise spans from supporting federal civilian agencies to defense, intelligence and homeland security organizations, as well as select commercial industries.
Key offerings include data analytics and artificial intelligence applications, software development and modernization, systems integration, and cyber risk management.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Booz Allen Hamilton Right Now?Before you consider Booz Allen Hamilton, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Booz Allen Hamilton wasn't on the list.
While Booz Allen Hamilton currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
GE Vernova Inc (NYSE:GEV) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.
Understanding the Power Inflow Signal
Order flow analytics examine real-time buying and selling behavior by analyzing volume, timing, and order size across both retail and institutional participants. These insights provide a deeper understanding of price action and market sentiment, allowing traders and institutions to make more informed decisions.
GEV Performance
At the time of the Power Inflow alert, GEV was trading at $1,001.20. Following the signal:
• Intraday High: $1,041.79 (+4.05%)
This article is for informational purposes only and does not constitute financial advice, investment recommendations, or a solicitation to buy or sell securities. The analysis is based on stock order flow data, but accuracy is not guaranteed. Investing involves risk, including possible loss of principal, and past performance is not indicative of future results. Please consult a licensed financial advisor before making any investment decisions.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.
Market News and Data brought to you by Benzinga APIs
Poprvé od ledna loňského roku se výnos desetiletých amerických státních dluhopisů vyšplhal k hranici 4,7 %. Hlavním zdrojem tlaku na růst výnosů zůstává cena ropy, která ve čtvrtek opět překonala hranici 100 dolarů za barel.
Americké desetileté dluhopisy představují klíčový benchmark, od kterého se odvíjejí hypoteční sazby, úroky z kreditních karet i náklady na financování automobilů. Během pátečního obchodování výnos mírně klesal a aktuálně se pohybuje kolem 4,68 %.
— Barchart (@Barchart) July 24, 2026 Konflikt na Blízkém východě dostal pod tlak také dvouleté státní dluhopisy, které jsou citlivější na kroky a rétoriku americké centrální banky. Jejich výnos od začátku roku vzrostl o 85 bazických bodů na 4,33 %. Růst krátkého konce výnosové křivky naznačuje, že investoři počítají s dalším zpřísňováním měnové politiky Fedu.
Trh aktuálně zaceňuje dvě zvýšení sazeb do konce ledna příštího roku, přičemž k prvnímu navýšení o 25 bazických bodů by podle současných očekávání mělo dojít již v září.
Pod tlakem zůstávají také třicetileté americké dluhopisy. Jejich výnos od roku 2022 stabilně roste a na začátku července překonal hranici 5 %. Nad touto úrovní se aktuálně drží zhruba 28 dní, což je nejdelší období od začátku globální finanční krize v roce 2007.
Pro investory je zajímavé, že na růstu výnosů se stále více podílejí nejen inflační očekávání, ale také reálné výnosy. Ty představují výnos, který investor získává nad míru inflace, a jsou důležitým ukazatelem očekávání trhu ohledně ekonomického růstu, měnové politiky i atraktivity rizikových aktiv.
Výnos desetiletých amerických TIPS se aktuálně pohybuje kolem 2,42 %. Zároveň roste jeho podíl na celkovém výnosu desetiletých amerických dluhopisů. To naznačuje, že investoři dnes nepožadují pouze kompenzaci za vyšší inflaci, ale také vyšší prémii za držení dlouhodobých amerických aktiv.
Rostoucí reálné výnosy zároveň představují riziko pro akcie, protože zvyšují atraktivitu relativně bezpečnějších dluhopisů. Vyšší reálné sazby se zároveň promítají do vyšší diskontní sazby používané při oceňování akcií, což snižuje současnou hodnotu budoucích zisků a cash flow. V konečném důsledku tak mohou vytvářet tlak na valuace i cílové ceny akcií.
Cena ropy dnes korigovala část včerejších nárůstu poté, co se nenaplnily obavy z úplného zastavení námořní dopravy v Rudém moři a průlivu Bab al-Mandab po včerejším útoku jemenských povstalců. Západoevropské burzy tak umazaly část včerejších poklesů a ve zlepšeném sentimentu se do plusu vrátila i pražská burza. Index PX nakonec posílil o 0,72 % na 2 654 bodů. Dařilo se především finančnímu sektoru. Erste Bank se zvedla o 0,84 % na 2 762 Kč a pojišťovna VIG přidala 0,76 % na 1 593 Kč. Moneta Money Bank po dnešním výsledkovém reportu a navýšeném výhledu stoupla o 1,91 % nad 192 Kč. Komerční banka si potom polepšila o 1,69 % na 1 022 Kč. Naopak zbrojovka CSG korigovala část zisků z tohoto týdne a ubrala 3,52 % na 378 Kč. ČEZ oslabil o mírných 0,15 % na 1 347 Kč.
Key Takeaways D-Wave expects modest Q2 revenue growth, with much of 2026 revenues recognized in the second half.QBTS first-quarter Bookings reached $31.8M, with commercial customers accounting for more than 31%.D-Wave's RPO totaled $42.4M, with 54% expected as revenues in the next 12 months. D-Wave Quantum (QBTS - Free Report) , or D-Wave, expects second-quarter 2026 revenues to be modestly higher than the first quarter, with the majority of the year's revenues likely to be recognized in the second half. The pattern reflects the timing of revenue recognition related to systems transactions, the company’s remaining performance obligations (RPOs) and its sales pipeline.
D-Wave notes that the system sales typically involve site preparation, delivery, installation and calibration before it becomes fully operational. These activities often span several months or quarters. The company recognizes a significant portion of revenues when a system is physically delivered, while a smaller portion is recognized over time as installation and calibration activities advance.
This was also seen in the first quarter of 2026, where revenues fell 81% year over year to $2.9 million, as the prior-year period included $12.6 million from the first sale of D-Wave’s annealing quantum computer system. However, first-quarter Bookings climbed to $33.4 million from $1.6 million a year earlier, with commercial customers accounting for more than 31% of Bookings. The balance came from educational and research organizations, led by the $20 million system sale to Florida Atlantic University.
D-Wave’s sales opportunity pipeline more than doubled in dollar value during the first quarter compared with the prior quarter, while the average potential deal size also more than doubled.
As of March 31, RPO related to unsatisfied or partially unsatisfied customer contracts totaled $42.4 million, up 563% from the first quarter of 2025 balance. Approximately 54% of this amount is expected to be recognized as revenues in the next 12 months and 71% within the next two years, with the remainder to be recognized thereafter.
Latest Developments Among QBTS PeersIBM (IBM - Free Report) has signed a definitive agreement to acquire HRL Laboratories, LLC (HRL), a private company jointly owned by Boeing and General Motors. HRL's silicon-spin qubit engineering expertise strengthens IBM’s push to scale increasingly powerful quantum computers. Both superconducting qubits and spin qubits leverage state-of-the-art silicon fabrication, offering credible paths to scaling quantum technologies.
Intel (INTC - Free Report) delivered a solid second-quarter 2026, with revenues up 25% year over year, marking its strongest revenue growth in more than 15 years. In the data center AI group, the quarter’s server growth was the strongest on record, while Xeon 6 continues to remain one of the fastest ramping-up products in Intel history, reflecting improving execution and strong customer demand. Intel also made steady progress in its newly announced design services business, with revenues nearly tripling year over year.
The Zacks Rundown for QBTS StockOver the past year, QBTS shares have declined 9% compared with the industry’s 17.6% fall.
Image Source: Zacks Investment Research
D-Wave is trading at a forward, 12-month Price/Sales (P/S) of 91.68X compared with its 164.72X median and the industry average of 3.85X.
Image Source: Zacks Investment Research
As shown below, analyst estimates for D-Wave’s 2026 and 2027 loss per share have remained stable over the past 60 days.
Image Source: Zacks Investment Research
D-Wave currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways SMMT reported a wider-than-expected Q2 loss and ended the quarter with higher cash after ATM fundraising.Summit submitted updated ivonescimab survival data to the FDA during its ongoing BLA review.SMMT expanded ivonescimab efforts with late-stage studies and a new Arcus collaboration. Summit Therapeutics (SMMT - Free Report) reported a second-quarter 2026 loss per share of 28 cents, wider than the Zacks Consensus Estimate of a loss of 26 cents per share. In the year-ago period, the company had incurred a loss of 76 cents per share.
The company currently lacks a marketed product in its portfolio. As a result, it did not record revenues in the quarter.
More on SMMT’s Q2 ResultsResearch and development (R&D) expenses were $157.7 million, down 24.2% year over year. General and administrative expenses plunged 82.6% year over year to $62.8 million. The substantial decline in operating costs was primarily due to a significant reduction in stock-based compensation expenses. However, total operating expenses increased 13% sequentially, reflecting higher R&D spending associated with the continued clinical development of ivonescimab.
As of June 30, 2026, Summit had cash, cash equivalents and short-term investments totaling $690.7 million, compared with $598.7 million as of March 31, 2026.
During the second quarter of 2026, Summit raised $230.8 million in gross proceeds through its at-the-market (ATM) facility, followed by an additional $68.4 million in gross proceeds after quarter-end, further strengthening its liquidity position.
SMMT’s Pipeline UpdatesThe lead program in the company’s pipeline is ivonescimab, a dual PD-1/VEGF inhibitor being evaluated in multiple late-stage studies across different settings in non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). SMMT is developing ivonescimab in collaboration with China-based Akeso. Ivonescimab is currently approved only in China for two distinct NSCLC indications.
In January, the FDA accepted the company's biologics license application (BLA) seeking approval for ivonescimab plus chemotherapy in patients with EGFR-mutant, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with third-generation EGFR-TKIs. The BLA filing was based on encouraging September 2025 results from the phase III HARMONi study. The FDA decision is expected by Nov. 14, 2026.
In July 2026, Summit reported more favorable OS data from the HARMONi study, with longer follow-up, demonstrating a consistent survival benefit with ivonescimab across Western and Asian patient populations. The analysis showed a hazard ratio (HR) of 0.76 in the overall intent-to-treat population, with the same HR of 0.76 observed independently in both the Western and Asian subgroups, reinforcing the geographic consistency of the treatment benefit.
The updated OS data have been submitted to the FDA as part of the ongoing BLA review, which could extend the FDA’s review timeline.
Year to date, shares of SMMT have lost 14.4% compared with the industry’s 3.9% decline.
Image Source: Zacks Investment Research
The company is evaluating ivonescimab in three late-stage studies, two in NSCLC (HARMONi-3 and HARMONi-7) and one in CRC (HARMONi-GI3).
HARMONi-3 is evaluating the drug against Merck’s (MRK - Free Report) blockbuster PD-L1 drug Keytruda (pembrolizumab) as a first-line treatment for metastatic squamous or non-squamous NSCLC, while HARMONi-7 is evaluating ivonescimab monotherapy in patients with first-line metastatic NSCLC whose tumors have high PD-L1 expression.
In the HARMONi-3 study, under the revised design, squamous and non-squamous NSCLC cohorts are being analyzed separately, with progression-free survival (PFS) and overall survival as primary endpoints. Patient enrollment in both cohorts has been completed. The final PFS results are expected in the second half of 2026 and in the first half of 2027 for the squamous and non-squamous NSCLC cohorts, respectively.
Patient enrollment in the phase III HARMONi-GI3 study, evaluating the candidate in combination with chemotherapy against bevacizumab plus chemotherapy in first-line unresectable metastatic colorectal cancer, is ongoing.
The company agreed to divest its investigational antibiotic, ridinilazole to Toronto-based Biossil Inc. in mid-July. The late-stage asset is being developed for the treatment of patients with clostridioides difficile infection, a serious bacterial infection of the colon. Per the agreement, Biossil will assume responsibility for the further development and commercialization of ridinilazole. In return, Summit will receive an upfront payment of $500,000 and will be eligible for up to $104.5 million in regulatory and commercial milestones, plus tiered royalties on net sales.
In July, Summit announced a collaboration with Arcus Biosciences (RCUS - Free Report) to evaluate RCUS' investigational HIF-2α inhibitor, casdatifan, in combination with ivonescimab for the treatment of clear cell renal cell carcinoma, including first-line metastatic disease. Arcus will sponsor and conduct the study, while both companies will share development costs and retain commercial rights to their respective therapies. Initial study data are expected by mid-2027.
SMMT’s Zacks Rank Summit currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Mark Cuban’s line landed as a joke, but it carried a thesis. Speaking on the All-In podcast, the Dallas Mavericks minority owner and Dallas Flash pickleball team co-owner predicted that as AI models and data centers become more efficient, much of today’s frantic buildout will look redundant, and that “a lot of data centers are going to be turned into pickleball courts.” Meanwhile, in northern Utah, that abstract skepticism now has a concrete case study: Kevin O’Leary’s roughly $100 billion Stratos Project has been forced into a real-world diet, and the fallout is still spreading.
Cuban’s Warning: Planning for Perfection Cuban was careful to say he does not think the AI boom is another dot-com-style bubble, describing the scale as narrower and the potential fallout more contained. His worry is downstream: if efficiency gains outrun demand, the overbuild could still “destroy” venture capital funds, hedge funds, and private equity firms that have underwritten the boom. Big Tech, he argued, is borrowing heavily and committing to years of capital expenditure, a stance he called “planning for perfection.”
The macro backdrop makes his math harder to dismiss. The 10-year Treasury yield sits at 4.67% as of July 22, 2026, near its 12-month high. For projects with multi-year debt stacks, every basis point compounds.
The Stratos Project Meets Utah Politics O’Leary’s venture in Box Elder County, north of the Great Salt Lake, was originally pitched as an AI campus spanning more than 40,000 acres with a power demand of roughly 9 gigawatts, promising about 2,000 permanent jobs and a Pentagon-linked national security angle. Box Elder County approved it in May 2026.
The state pushed back almost immediately. Utah Senate President Stuart Adams called for a 75% reduction in the footprint, and Governor Spencer Cox signed an executive order on May 29, 2026 requiring proper state evaluation of large data center proposals. O’Leary first called the demands “outrageous,” then reversed and agreed to shrink the site from roughly 40,000 acres to just over 20,000. He later conceded in an interview: “The two of us really screwed this up initially… We made huge mistakes… We pissed off a lot of people, and that’s not the way I do business.”
The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.
Water, the Lake, and a Lawsuit The binding constraint was water. Utah’s Great Salt Lake has been shrinking for years, and residents were not eager to let a 9-gigawatt server farm draw from a stressed basin. Data center cooling is thirsty work: U.S. facilities consumed an estimated 66 billion liters of water in 2023, per the Department of Energy, with an indirect footprint from electricity generation of nearly 800 billion liters. O’Leary pledged industry-leading water technology and committed any excess supply to the lake itself.
The story is still live. On July 17, 2026, two Utah advocacy groups sued O’Leary and Fox News for defamation after he claimed, without evidence and later walked back, that opposition to the project was funded by the Chinese Communist Party.
What to Watch Cuban’s pickleball court prediction may or may not age well. The rest of the sector is still leaning in: OpenAI announced a 3.2 gigawatt campus in Effingham County, Georgia, and Hut 8 (NASDAQ:HUT) secured a $9.8 billion lease for its Texas campus this week. But Stratos is what Cuban’s warning looks like when it meets zoning boards, governors, and a drying lake. The signal to watch next quarter is whether other mega-sites, in Texas, Georgia, and Wyoming, run into their own Stuart Adams before a shovel hits the dirt.
If You'd Bought Amazon When the Motley Fool Said To…In September 2002, Stock Advisor told subscribers to buy Amazon. In December 2004, Netflix. In April 2005, Nvidia. The newsletter still publishes two new stock picks every month — and over 23 years, has more than quadrupled the S&P 500. Here's how to get this month's picks:
- Join Stock Advisor for one year, with a 30-day money-back guarantee
- Get this month's two new picks — plus the Top 10 Rankings and the full historical pick list
- Read the analysis, decide for yourself, and trade through your own brokerage
Five years from now, you'll probably wish you'd bought this month's picks. Don't miss them.
Key Takeaways Sonoco's Q2 adjusted EPS beat estimates as pricing, FX and productivity offset softer volume and mix.Productivity savings reached $10 million in Q2, bringing annualized savings to about $38 million.Sonoco reaffirmed its 2026 guidance, expecting adjusted EPS near the low end of $5.80-$6.20. Sonoco Products Company (SON - Free Report) reported adjusted earnings of $1.51 per share in the second quarter of 2026, beating the Zacks Consensus Estimate of $1.47 by 2.72%. The figure rose 10.2% from $1.37 in the year-ago quarter. Pricing actions, favorable foreign-exchange movements and productivity gains helped offset softer volume/mix during the quarter.
Including one-time items, the company reported earnings of $1.05 per share from continuing operations compared with 69 cents in the year-ago quarter. Including discontinued operations, second-quarter 2026 earnings were $1.05 compared with $4.96 in the year-ago quarter.
Net sales of $1.885 billion declined 1.3% year over year and missed the consensus mark of $1.886 billion by 0.05%. SON’s top line declined from the prior-year period primarily due to the absence of sales from the ThermoSafe business, which was divested in November 2025.
The profitability performance program delivered $10 million in savings during the quarter. Annualized savings reached approximately $38 million, representing 25% of the minimum target under Sonoco’s three-year goal of $150-$200 million.
Sonoco’s Gross Profit Falls in Q2The cost of sales was $1.49 billion, down 0.7% from the year-earlier quarter. Gross profit totaled $392 million, declining 3.4% year over year. The gross margin was 20.8% compared with 21.3% in the prior-year quarter.
Selling, general and administrative expenses amounted to $200 million, down 8.5% year over year.
Adjusted operating income was $242 million, down 1.8% from the prior-year quarter’s $246.9 million. The adjusted operating margin was 12.9%, broadly unchanged year over year.
Adjusted EBITDA was $324 million, down 1.2% from the year-ago quarter.
Sonoco’s Segmental PerformanceThe Consumer Packaging segment’s net sales rose 1.2% year over year to $1.24 billion. The increase reflected pricing actions to offset inflation and tariff-related costs, along with favorable foreign-currency movements, partially offset by softer volumes. The segment’s adjusted EBITDA amounted to $206.7 million, down 3.1% from the prior-year quarter.
Net sales in the Industrial Paper Packaging segment were $643.6 million, reflecting year-over-year growth of 4.2%. The increase was driven by successful pricing actions and favorable foreign exchange. Adjusted segment EBITDA totaled $122.2 million, up 2.9% year over year, as productivity and procurement savings helped offset higher raw-material, freight and other operating costs.
Sonoco’s Cash Flow & Balance Sheet UpdatesThe operating cash flow reached a second-quarter record of $301 million, up 56% year over year. The free cash flow climbed 139% to $237 million, reflecting disciplined working-capital management and a capital expenditure of $64 million.
Cash and cash equivalents were $168.6 million at the quarter-end, down from $378.4 million at the end of the prior-year quarter. Total debt and net debt stood at $4.5 billion and $4.3 billion, respectively, while available liquidity totaled $1.3 billion.
SON Reaffirms 2026 OutlookSonoco maintained its 2026 net sales guidance of $7.25-$7.75 billion and the adjusted EBITDA outlook of $1.25-$1.35 billion. The company also reiterated its operating cash flow forecast of $700-$800 million.
Adjusted earnings guidance is pegged at $5.80-$6.20 per share, with the company continuing to expect results near the low end. Pricing actions, contract resets and productivity initiatives are expected to improve margins in the second half, although inflation and macroeconomic uncertainty remain the key risks.
Sonoco’s Price PerformanceThe company’s shares have gained 21.2% in the past year against the industry’s 5.3% decline.
Image Source: Zacks Investment Research
SON’s Zacks RankPackaging Stocks Awaiting ResultsBall Corporation (BALL - Free Report) is scheduled to release second-quarter 2026 results on Aug. 4. The Zacks Consensus Estimate for BALL’s second-quarter 2026 earnings is pegged at 99 cents per share, suggesting year-over-year growth of 10%.
The Zacks Consensus Estimate for Ball Corp’s top line is pegged at $3.67 billion, indicating growth of 9.8% from the prior-year reported figure. Ball Corp has a trailing four-quarter average surprise of 3.7%.
Silgan Holdings Inc. (SLGN - Free Report) is scheduled to release second-quarter 2026 results on July 29. The Zacks Consensus Estimate for SLGN’s second-quarter 2026 earnings is pegged at 96 cents per share, implying a year-over-year dip of 4.9%.
The Zacks Consensus Estimate for Silgan Holdings’ top line is pegged at $1.62 billion, suggesting an increase of 5.1% from the prior-year reported figure. Silgan Holdings has a trailing four-quarter average surprise of 1.8%.
AptarGroup, Inc. (ATR - Free Report) is scheduled to release second-quarter 2026 results on July 30. The Zacks Consensus Estimate for AptarGroup’s second-quarter 2026 earnings is pegged at $1.34 per share, indicating a year-over-year dip of 19.3%.
The Zacks Consensus Estimate for the company’s top line is pegged at $1 billion, implying growth of 3.8% from the prior-year reported figure. ATR has a trailing four-quarter average surprise of 3.1%.
Investors in Capri Holdings Limited (CPRI - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug. 21, 2026 $7.5 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for Capri Holdings shares, but what is the fundamental picture for the company? Currently, Capri Holdings is a Zacks Rank #3 (Hold) in the Retail - Apparel and Shoes industry that ranks in the Top 21% of our Zacks Industry Rank. Over the last 60 days, three analysts have increased their earnings estimates for the to-be-reported quarter, while one has dropped the estimates. The net effect has taken our Zacks Consensus Estimate for the to-be-reported quarter from 39 cents per share to 44 cents in that period.
Given the way analysts feel about Capri Holdings right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
PANews July 24 news, according to official sources, the Gate stock copy trading feature has officially launched. After updating the Gate App, users can access the "Copy Trading > Stocks" entry to follow traders and replicate real stock positions in real time, covering U.S. stocks, Hong Kong stocks, Korean stocks, and all-category ETFs, encompassing 12,500 stocks and ETF targets. The product adopts a proportional copy trading and fractional share trading mechanism, allowing participation with as little as 0.01 shares; it also introduces an HWM high-water mark profit-sharing mechanism, where lead traders only receive new profit shares after the cumulative net profit of copy trading users breaks through the historical high.
In conjunction with this product debut, Gate is launching a stock copy trading launch event from July 24, 2026 14:00 to August 13, 14:00 (UTC+8), with a total prize pool of 70,000 USDT. Lead traders who apply to become stock lead traders during the event period, complete lead trades, or participate in trading volume rankings will have the chance to receive their first lead trading reward and share an exclusive trader prize pool. Copy trading users who try stock copy trading for the first time and complete the specified trading volume can enjoy loss subsidies; those who cumulatively follow different lead traders or join the copy trading sprint competition can also receive corresponding rewards.
This launch combines Gate's real stock market access capabilities with the copy trading mechanism, lowering the barrier for users to participate in multi-market stock and ETF trading; the accompanying event simultaneously incentivizes trader onboarding and optimizes user experience, driving the startup and active growth of the stock copy trading ecosystem.
PANews, July 24 – According to an official announcement, Gate IPO Access’s second phase project, Jersey Mike’s (JMKE), will open for indication of interest subscriptions on July 27, 2026, at 10:00 (UTC+8). Users can participate using USDT or GUSD, with the opportunity to obtain corresponding stock shares and trade them through Gate’s stock section after listing. This subscription period will run until July 29, 2026, at 10:00 (UTC+8), with a reference subscription price of $21–$25 per share. The minimum investment is 100 USDT or 100 GUSD, and the maximum is 500,000 USDT or 500,000 GUSD, with no additional handling fees. Regarding subscription quotas, the USDT and GUSD subscription pools each account for 50%, and the platform will calculate the allotment ratio based on users’ average hourly locked amount during the subscription period.
This subscription is an “indication of interest” subscription. The final allotment results will be comprehensively determined based on the actual IPO offering situation, the allotment quota obtained by the platform, and user participation. Stocks successfully allotted are expected to be distributed to users’ Gate stock accounts on July 30, 2026, and can be traded through Gate’s stock section after listing. These stocks have no lock-up period and support 100% unlocking.
Currently, Gate has built a comprehensive trading system covering global stock markets, supporting over 12,500 stocks and ETF trading instruments, and has deployed products such as gStocks tokenized securities, Pre-IPOs, and IPO Access, covering diverse scenarios including pre-IPO opportunity capture, public market trading, and tokenized securities investment. Going forward, Gate will continue to improve its multi-asset trading infrastructure, providing users with a more open and efficient one-stop global investment service.
OneSpan (OSPN - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares of this internet security company have returned +9% over the past month versus the Zacks S&P 500 composite's +0.6% change. The Zacks Internet - Software industry, to which OneSpan belongs, has gained 5.5% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
OneSpan is expected to post earnings of $0.25 per share for the current quarter, representing a year-over-year change of -26.5%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
The consensus earnings estimate of $1.23 for the current fiscal year indicates a year-over-year change of -17.5%. This estimate has remained unchanged over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $1.33 indicates a change of +8.1% from what OneSpan is expected to report a year ago. Over the past month, the estimate has remained unchanged.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, OneSpan is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For OneSpan, the consensus sales estimate for the current quarter of $57.75 million indicates a year-over-year change of -3.5%. For the current and next fiscal years, $246.53 million and $256.09 million estimates indicate +1.4% and +3.9% changes, respectively.
Last Reported Results and Surprise HistoryOneSpan reported revenues of $65.95 million in the last reported quarter, representing a year-over-year change of +4.1%. EPS of $0.39 for the same period compares with $0.45 a year ago.
Compared to the Zacks Consensus Estimate of $60.94 million, the reported revenues represent a surprise of +8.22%. The EPS surprise was +8.33%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates two times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
OneSpan is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about OneSpan. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
GigaCloud Technology Inc. (GCT - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this company have returned +12.8% over the past month versus the Zacks S&P 500 composite's +0.6% change. The Zacks Technology Services industry, to which GigaCloud Technology Inc. belongs, has lost 3% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, GigaCloud Technology Inc. is expected to post earnings of $0.85 per share, indicating a change of -6.6% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $4.18 points to a change of +16.4% from the prior year. Over the last 30 days, this estimate has remained unchanged.
For the next fiscal year, the consensus earnings estimate of $4.83 indicates a change of +15.6% from what GigaCloud Technology Inc. is expected to report a year ago. Over the past month, the estimate has remained unchanged.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for GigaCloud Technology Inc..
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
In the case of GigaCloud Technology Inc., the consensus sales estimate of $383.7 million for the current quarter points to a year-over-year change of +18.9%. The $1.53 billion and $1.65 billion estimates for the current and next fiscal years indicate changes of +19% and +7.5%, respectively.
Last Reported Results and Surprise HistoryGigaCloud Technology Inc. reported revenues of $359.49 million in the last reported quarter, representing a year-over-year change of +32.2%. EPS of $1.04 for the same period compares with $0.68 a year ago.
Compared to the Zacks Consensus Estimate of $344.9 million, the reported revenues represent a surprise of +4.23%. The EPS surprise was +19.54%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
GigaCloud Technology Inc. is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about GigaCloud Technology Inc.. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
TAIPEI, Taiwan and MILPITAS, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or the “Company”), a global leader in designing and marketing NAND flash controllers for solid state storage devices, confirms today its quarterly cash dividend.
On October 27, 2025, the Board of Directors of the Company declared payment of an annual dividend of US$2.00 per ADS1, equivalent to US$0.50 per ordinary share, which will be paid in four quarterly installments of $0.50 per ADS, equivalent to US$0.125 per ordinary share. According to the previously announced record and payment dates, the next quarterly installment will be paid on August 20, 2026 to all shareholders of record on August 6, 2026. Our depository bank’s DR Books will be closed for issuance and cancellation on August 6, 2026.
The declaration and payment of future cash dividends are subject to the Board's continuing determination that the payment of dividends is in the best interests of the Company’s shareholders and are in compliance with all laws and agreements of the Company applicable to the declaration and payment of cash dividends.
ABOUT SILICON MOTION:
We are the global leader in supplying NAND flash controllers for solid state storage devices. We supply more SSD controllers than any other company in the world for servers, PCs and other client devices and are the leading merchant supplier of eMMC and UFS embedded storage controllers used in smartphones, IoT devices and other applications. We also supply customized high-performance hyperscale data center and specialized industrial and automotive SSD solutions. Our customers include most of the NAND flash vendors, storage device module makers and leading OEMs. For further information on Silicon Motion, visit us at www.siliconmotion.com.
FORWARD-LOOKING STATEMENTS:
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or the negative of these terms or other comparable terminology. Although such statements are based on our own information and information from other sources we believe to be reliable, you should not place undue reliance on them. These statements involve risks and uncertainties, and actual market trends or our actual results of operations, financial condition or business prospects may differ materially from those expressed or implied in these forward-looking statements for a variety of reasons. Potential risks and uncertainties include, but are not limited to the unpredictable volume and timing of customer orders, which are not fixed by contract but vary on a purchase order basis; the loss of one or more key customers or the significant reduction, postponement, rescheduling or cancellation of orders from one or more customers; general economic conditions or conditions in the semiconductor or consumer electronics markets; the impact of inflation on our business and customer’s businesses and any effect this has on economic activity in the markets in which we operate; the functionalities and performance of our information technology (“IT”) systems, which are subject to cybersecurity threats and which support our critical operational activities, and any breaches of our IT systems or those of our customers, suppliers, partners and providers of third-party licensed technology; the effects on our business and our customer’s business taking into account the ongoing U.S.-China tariffs and trade disputes; other factors beyond our control such as nature disasters, terrorism, civil unrest, war, including conflicts in the Middle East, threats to the Strait of Hormuz and global energy supply routes, and the ongoing Russia-Ukraine War, and pandemics, epidemics and other health emergencies; the continuing tensions between Taiwan and China, including enhanced military activities; decreases in the overall average selling prices of our products; changes in the relative sales mix of our products; supply chain disruptions that have affected us and our industry as well as other industries on a global basis; the payment, or non-payment, of cash dividends in the future at the discretion of our Board of Directors and any announced planned increases in such dividends; changes in our cost of finished goods; the availability, pricing, and timeliness of delivery of other components and raw materials used in the products we sell given the current raw material supply shortages being experienced in our industry; our customers’ sales outlook, purchasing patterns, and inventory adjustments based on consumer demands and general economic conditions; any potential impairment charges that may be incurred related to businesses previously acquired or divested in the future; the risk that the anticipated benefits from our PCIe 5 controller products, including higher [average selling prices], may not be maintained or may be less than expected; the risk that our anticipated market share gains across our product lines and penetration of enterprise end markets may not materialize as expected or on the anticipated timeline; our ability to successfully develop, introduce, and sell new or enhanced products in a timely manner; and the timing of new product announcements or introductions by us or by our competitors. For additional discussion of these risks and uncertainties and other factors, please see the documents we file from time to time with the U.S. Securities and Exchange Commission, including our Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission on April 30, 2026. Other than as required under the securities laws, we do not intend, and do not undertake any obligation to, update or revise any forward-looking statements, which apply only as of the date of this news release.
Investor Contact:Investor Contact:Tom SepenzisSelina HsiehVice President of Investor Relations & StrategyInvestor RelationsE-mail: [email protected] E-mail: [email protected] Media Contact: Minnie Lin Director of Marketing Communication Department E-mail: [email protected]
1 One ADS is equivalent to four ordinary shares.
Mubadala Capital has launched tokenized access to an evergreen private market strategy through UAE-based infrastructure provider KAIO.
Summary
Mubadala Capital’s tokenized private markets strategy attracted about $75 million across Solana, Base and Sui. Coinbase will add undisclosed fund exposure to its balance sheet, moving beyond infrastructure support alone. KAIO limits access to qualified investors while handling regulated issuance, administration and multichain fund distribution. The offering is available on Base, Solana and Sui and has attracted about $75 million from traditional and digital-asset investors.
Coinbase will take an undisclosed position in the product and place the exposure on its balance sheet. The exchange is acting as an investor rather than only a network or service provider. Access remains limited to qualified institutional and accredited investors.
Mubadala private markets strategy moves onchain The product is tied to the Mubadala Capital Alternative Solutions Fund, an evergreen strategy with exposure to private equity, direct investments and credit. KAIO handles the tokenized structure, investor access and onchain administration across the three networks.
Mubadala Capital is the alternative asset management subsidiary of Abu Dhabi’s Mubadala Investment Company. Its official website says the platform manages, advises and administers more than $600 billion through its businesses and partnerships. Its alternative investment operations report about $60 billion in assets under management.
The launch follows an official partnership announced in December 2025. Mubadala Capital and KAIO said they would explore regulated digital access to private market investments for eligible investors. They said the structure would retain governance, regulatory controls and investment oversight.
Max Franzetti, head of Mubadala Capital Solutions, said, “Bringing it onchain extends that access to a new class of qualified investors.” The companies did not disclose minimum investments, fees, redemption terms or the number of participating investors.
Coinbase adds the fund to its balance sheet Coinbase’s role goes beyond providing Base as one settlement network. The company said it would add exposure to the tokenized offering to its balance sheet. It did not disclose the value, timing or accounting treatment.
Brett Tejpaul, head of Coinbase Institutional, linked the purchase to growing use of regulated tokenized assets. The transaction gives Coinbase economic exposure to a sovereign-backed private markets product while it continues building services for onchain funds.
Coinbase Asset Management launched the CUSHY tokenized credit strategy in April. That product targets public digital credit, private asset-backed lending and tokenization-related returns across Ethereum, Solana and Base. The Mubadala position adds a separate private markets asset to Coinbase’s holdings.
Coinbase’s involvement does not make the product available to retail users. The fund keeps the eligibility requirements attached to private investments. Transfers must follow KAIO’s compliance controls and rules set by the fund and its regulated providers.
KAIO distributes the product across three networks KAIO provides infrastructure for regulated issuance and management of tokenized funds. Its platform documentation says the system supports compliance and lifecycle management while allowing tokenized assets to move across public networks. Deployment on Base, Solana and Sui gives approved investors several network options.
Tokenization can shorten administrative steps and provide faster ownership updates. It may also allow approved fund interests to interact with digital custody, collateral and settlement systems. However, a blockchain token does not remove lockups, valuation limits or transfer rules tied to private assets.
KAIO previously supported onchain products linked to BlackRock, Brevan Howard, Hamilton Lane and Nomura’s Laser Digital. As previously reported, Tether led an $8 million KAIO funding round in April, bringing total funding to $19 million.
The firm later launched its KAIO governance token and foundation. Crypto.news reported that KAIO had about $100 million in tokenized fund value then. The Mubadala launch adds a sovereign-backed manager and about $75 million in announced commitments.
Solana tokenization activity continues to grow Solana promoted the launch as the arrival of Mubadala Capital’s Alternative Solutions Fund on its network. Base and Sui also host the structure, so it is not exclusive to Solana. KAIO has not published how the $75 million is divided across the chains.
Institutional fund launches on Solana have increased during 2026.State Street and Galaxy launched the SWEEP tokenized cash management fund on Solana in May. Securitize later brought an AAA-rated collateralized loan obligation fund to the network, with Ethena planning a $250 million allocation.
The Mubadala product differs from tokenized Treasury and cash funds because it gives eligible investors exposure to an evergreen private markets strategy. Private assets usually have longer holding periods and less frequent pricing than cash-equivalent products.
The companies have not announced retail access or open secondary trading. They also have not said whether the tokens can serve as collateral in outside applications. The launch provides regulated, multichain access to qualified investors while Coinbase tests the product as a corporate balance-sheet asset at this early stage.
SanDisk stock price has slumped into a bear market after falling by 33% from its highest point this year. It dropped to $1,610, mirroring the performance of other memory and semiconductor companies. Still, despite this retreat, analysts are highly optimistic about the company ahead of its earnings release on August 13.
Aaron Rakers, a Wells Fargo analyst, boosted his target for SanDisk shares from $1,250 to $1,620 this week. He joined other analysts who have either boosted their targets or maintained.
EverCore ISI set a price target of $3,100, representing a big jump from the current level. Matt Bryson, a Wedbush analyst, hiked his target for the stock from $1,200 to $2,000, while Wamsi Mohan, a Bank of America analyst, hiked the target to $2,500.
Other analysts who boosted their targets recently were from companies like Bernstein, Citigroup, and Cantor Fitzgerald.
The general view among these analysts is that the artificial intelligence boom is still going on and there is no need for investors to panic.
To a large extent, recent earnings by some of the biggest companies shows that their revenue and earnings growth is surging. For example, Intel stock is soaring today after the semiconductor company published strong results.
Micron, the third-biggest player in the high-bandwidth memory (HBM) industry showed that its revenue jumped by over 300%. In another note, Samsung Electronics also released strong numbers.
Most notably, big-tech companies are still committed to their spending. For example, Alphabet predicts that it will spend over $205 billion this year. More big-tech companies may continue this spending when they release their numbers next week.
Most importantly, SanDisk has entered several long-term supply agreements with its biggest customers. This approach is aimed at helping to reduce the boom and bust cycles that have been associated with the memory industry.
Three of these deals are worth at least $42 billion, with the contracts ranging between 1 and five years. Notably, these contracts include floors and ceilings, limiting downside and upside volatility.
The next important catalyst for the SNDK stock price will be its August 8 earnings, which will provide details of its performance.
These earnings are expected to show that the company had the best quarter ever, with its revenue coming in at $8.40 billion, up by 349%. This is a big milestone for a company that made $7.3 billion in the last financial year.
If this view is correct, then its annual revenue will be $19.8 billion, up by 170% from the same period last year. Its annual revenue in the next financial year will be $50.3 billion. Judging by the recent tech earnings, chances are that it will publish stronger results than expected.
A key risk facing SanDisk is that big tech companies may start reducing their spending in the coming months or years. If this happens, demand will likely wane, affecting memory companies.
READ MORE: Micron stock gets an unexpected clue from China’s latest AI experiment
SanDisk stock chart | Source: TradingView
SanDisk is also facing some technical risks. It has slipped below the 50-day Exponential Moving Average (EMA) and the 23.6% Fibonacci Retracement level.
The stock has also formed what looks like a head-and-shoulders pattern, a common bearish sign. There are also signs that the stock is moving from the markup phase of the Wyckoff Theory into the distribution stage.
Therefore, the stock will likely resume the downtrend, potentially to the psychological level of $1,000.
